Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting
Vegf Mrna Stabilization Mechanisms in Tumor Angiogenesis
Sexuality, HIV/Drug in 3 Groups of Asian/Gay/Bi Men/MSM
Methods to Detect HIV and Related Retroviruses
Recently added grants:
Bio-Behavioral Core
Implementation Science and Health Outcomes Core
Quantifying the attentional template
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
Development Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-008
Application #
7329467
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant